Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q2 2022 Results - Earnings Call Transcript

Sangamo Therapeutics, Inc. (NASDAQ:NASDAQ:SGMO) Q2 2022 Earnings Conference Call August 04, 2022 04:30 PM ET Company Participants Louise Wilkie - Investor Relations Sandy Macrae - Chief...

Related Keywords

Australia ,Italy ,United States ,Canada ,Washington ,America ,American ,Gregory Harrison ,Jason Shieh ,Bettina Cockroft ,Gena Wang ,Harshita Polishetty ,Prathyusha Duraibabu ,Rob Schott ,Yanan Zhu ,Nicole Germino ,Sandy Macrae ,Mark Mcclung ,Louise Wilkie ,Greg Harrison ,Ben Burnett ,Andreas Argyrides ,Maury Raycroft ,Lisa Walter ,Jason Fontenot ,Company Participants ,European Commission ,Nasdaq ,Sangamo Therapeutics Inc ,Novartis ,Pfizer ,American Society Of Gene ,Safety Monitoring Committee ,Hc Wainwright Co ,Barclays ,Head Of Development ,Wells Fargo ,Sangamo Therapeutics ,Conference Call August ,Sangamo Second Quarter ,Vice President ,Investor Relations ,Chief Executive Officer ,Chief Operating Officer ,Chief Financial Officer ,Chief Scientific Officer ,Chief Medical ,Fabry Phase ,Zinc Finger ,American Society ,Cell Therapy ,Annual Meeting ,Inborn Errors ,Orphan Medicinal Product Designation ,European Medicines Agency Committee ,Orphan Medicinal ,Orphan Designation ,Regarding Fabry ,Ritu Baral ,Luca Issi ,